Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Time to Reconsider Evidence for Anaemia Treatment (TREAT) = Essential Safety Arguments (ESA).

× No keyword cloud information.

5 in total

Review 1. Mineral metabolism and vitamin D in chronic kidney disease--more questions than answers.

Authors: David J A Goldsmith; John Cunningham
Journal: Nat Rev Nephrol Date: 2011-05-03 Impact factor: 28.314

Review 2. The Janus faces of ESAs: caveat Chimaera!

Authors: Hugo Penny; Daniel Leckström; David Goldsmith
Journal: Int Urol Nephrol Date: 2012-09-13 Impact factor: 2.370

Review 3. Medication Safety Principles and Practice in CKD.

Authors: Chanel F Whittaker; Margaret A Miklich; Roshni S Patel; Jeffrey C Fink
Journal: Clin J Am Soc Nephrol Date: 2018-06-18 Impact factor: 8.237

4. A pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients: background and methodology of the MONITOR-CKD5 study.

Authors: Loreto Gesualdo; Gérard London; Matthew Turner; Christopher Lee; Karen Macdonald; David Goldsmith; Adrian Covic; Philippe Zaoui; Christian Combe; Johannes Mann; Frank Dellanna; Michael Muenzberg; Ivo Abraham
Journal: Intern Emerg Med Date: 2011-05-18 Impact factor: 3.397

5. Cross-sectional survey in CKD patients across Europe describing the association between quality of life and anaemia.

Authors: Daniel Eriksson; David Goldsmith; Siguroli Teitsson; James Jackson; Floortje van Nooten
Journal: BMC Nephrol Date: 2016-07-26 Impact factor: 2.388

5 in total